Literature DB >> 24742853

Brimonidine effective but may lead to significant rebound erythema.

Dan Ilkovitch1, Rebecca G Pomerantz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24742853     DOI： 10.1016/j.jaad.2014.01.853

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  8 in total

Review 1.  Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2017-07-01

Review 2.  Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies.

Authors:  Anna D Holmes; Kimberly A Waite; Michael C Chen; Kiruthi Palaniswamy; Thomas H Wiser; Zoe D Draelos; Elyse S Rafal; W Philip Werschler; Alison E Harvey
Journal:  J Clin Aesthet Dermatol       Date:  2015-08

3.  Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial.

Authors:  Jerry Tsai; Anna L Chien; Noori Kim; Saleh Rachidi; Brian M Connolly; Hester Lim; Sabrina Sisto Alessi César; Sewon Kang; Luis A Garza
Journal:  J Am Acad Dermatol       Date:  2021-02-03       Impact factor: 15.487

4.  The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea.

Authors:  Andrew William Johnson; Sandra Marchese Johnson
Journal:  Dermatol Ther (Heidelb)       Date:  2015-06-26

Review 5.  Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability.

Authors:  Michael S Anderson; Anish Nadkarni; Leah A Cardwell; Hossein Alinia; Steven R Feldman
Journal:  Patient Prefer Adherence       Date:  2017-07-06       Impact factor: 2.711

Review 6.  The role of brimonidine tartrate gel in the treatment of rosacea.

Authors:  J Mark Jackson; Melissa Knuckles; John Paul Minni; Sandra Marchese Johnson; Kevin Tate Belasco
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-23

Review 7.  Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy.

Authors:  James R Docherty; Martin Steinhoff; Dianne Lorton; Michael Detmar; Gregor Schäfer; Anna Holmes; Anna Di Nardo
Journal:  Adv Ther       Date:  2016-08-25       Impact factor: 3.845

Review 8.  Rosacea: Epidemiology, pathogenesis, and treatment.

Authors:  Barbara M Rainer; Sewon Kang; Anna L Chien
Journal:  Dermatoendocrinol       Date:  2017-10-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.